Soleno Therapeutics, Inc. (SLNO) Financial Statements (2024 and earlier)

Company Profile

Business Address 203 REDWOOD SHORES PARKWAY
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,60221,30449,22420,73323,09917,100
Cash and cash equivalents14,60221,30449,22420,73323,09917,100
Restricted cash and investments      35
Receivables     64 
Other undisclosed current assets1,0451,1181,0194111,507859
Total current assets:15,64722,42250,24321,14424,67017,994
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   1524
Operating lease, right-of-use asset131421124398
Property, plant and equipment263319221223
Intangible assets, net (including goodwill)10,69312,63714,58116,52518,46920,413
Intangible assets, net (excluding goodwill)10,69312,63714,58116,52518,46920,413
Other noncurrent assets 40 59 126
Other undisclosed noncurrent assets      466
Total noncurrent assets:10,85013,13114,73917,02818,48121,028
TOTAL ASSETS:26,49735,55364,98238,17243,15139,022
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,4523,9824,4942,278934633
Employee-related liabilities7281,005283  
Accounts payable1,7773,2543,4891,995934633
Accrued liabilities1,675     
Debt   8322  
Disposal group, including discontinued operation      127
Other liabilities484323196382  
Other undisclosed current liabilities3,3773,7023,9201,982943973
Total current liabilities:7,3138,0078,6184,9641,8771,733
Noncurrent Liabilities
Long-term debt and lease obligation  175 147  
Finance lease, liability    8
Liabilities, other than long-term debt   1474,0629,737
Deferred tax liabilities, net4,0624,417
Disposal group, including discontinued operation, liabilities      225
Other liabilities    147 13
Operating lease, liability 175 139
Business combination, contingent consideration, liability      5,082
Other undisclosed noncurrent liabilities8,8369,40310,81717,9676,7991,017
Total noncurrent liabilities:8,8369,75310,81718,26110,86110,754
Total liabilities:16,14917,76019,43523,22512,73812,487
Equity
Equity, attributable to parent, including:10,34817,79345,54714,94730,41326,535
Common stock88080453219
Additional paid in capital247,762231,068227,912172,708157,413140,495
Accumulated other comprehensive loss      
Accumulated deficit(237,422)(213,355)(182,445)(157,806)(127,032)(113,979)
Other undisclosed equity, attributable to parent      0
Total equity:10,34817,79345,54714,94730,41326,535
TOTAL LIABILITIES AND EQUITY:26,49735,55364,98238,17243,15139,022

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues
(Sublease Income)
    173  
Gross profit:    173  
Operating expenses(24,397)(31,528)(36,289)(23,486)(14,301)(12,171)
Other operating expense, net
(Other Nonrecurring (Income) Expense)
      (590)
Other undisclosed operating income (loss)    (173) 590
Operating loss:(24,397)(31,528)(36,289)(23,486)(14,301)(12,171)
Nonoperating income (expense)33061811,650(7,288)2,460(1,553)
Investment income, nonoperating     1,994 
Other nonoperating income (expense)30011013154(62)(1,553)
Interest and debt expense   (2)(1)  
Other undisclosed income from continuing operations before equity method investments, income taxes   21 27,449
Income (loss) from continuing operations before equity method investments, income taxes:(24,067)(30,910)(24,639)(30,774)(11,841)13,724
Loss from equity method investments    (478)(160) 
Other undisclosed income (loss) from continuing operations before income taxes     160(27,449)
Loss from continuing operations before income taxes:(24,067)(30,910)(24,639)(31,252)(11,841)(13,724)
Income tax benefit      1,650
Loss from continuing operations:(24,067)(30,910)(24,639)(31,252)(11,841)(12,074)
Loss before gain (loss) on sale of properties:(30,910)(24,639)(31,252)(13,335)(15,667)
Loss from discontinued operations     (1,494)(3,594)
Other undisclosed net income    478  
Net loss available to common stockholders, diluted:(24,067)(30,910)(24,639)(30,774)(13,335)(15,667)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(24,067)(30,910)(24,639)(30,774)(13,335)(15,667)
Comprehensive loss:(24,067)(30,910)(24,639)(30,774)(13,335)(15,667)
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive loss, net of tax, attributable to parent:(24,067)(30,910)(24,639)(30,774)(13,335)(15,667)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: